| Identification | Back Directory | [Name]
1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt | [CAS]
111130-13-3 | [Synonyms]
CGP 35949
N-[3-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-chloro-6-methylphenyl]-1H-tetrazole-5-carboxamide
1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt | [MOL File]
111130-13-3.mol |
| Hazard Information | Back Directory | [Description]
CGP 35949 is an LTD4 antagonist with phospholipase inhibitory activity. It represents a new approach to the treatment of asthma. | [Uses]
CGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity. CGP-35949 sodium can be used for research of asthma[1]. | [References]
[1] Beck A, et al. CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma. Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:771-4. PMID:2960189 |
|
|